Estimating the global disease burden due to ultraviolet radiation exposure

International Journal of Epidemiology

Volumn 37, Issue 3, 2008, Pages 654-667

  Lucas, Robyn M ^a   Mcmichael, Anthony J ^a   Armstrong, Bruce K ^b   Smith, Wayne T ^c  

^a The Australian National University   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Environmental exposures; Eye diseases; Risk assessment; Skin cancer; Ultraviolet rays; Vitamin D; World health

Indexed keywords

VITAMIN D;

CANCER; DISEASE INCIDENCE; DISEASE PREVALENCE; ENVIRONMENTAL RISK; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT; ULTRAVIOLET RADIATION; VITAMIN; WORLD HEALTH ORGANIZATION;

ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER MORTALITY; CATARACT; CONJUNCTIVA TUMOR; CORNEA TUMOR; DIET SUPPLEMENTATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; HEALTH HAZARD; HEALTH PROMOTION; HERPES LABIALIS; HUMAN; MELANOMA; OSTEOMALACIA; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; PTERYGIUM; QUANTITATIVE ANALYSIS; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; RADIATION HAZARD; RICKETS; RISK ASSESSMENT; RISK FACTOR; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SUNBURN; SUNLIGHT PROTECTION; ULTRAVIOLET RADIATION; VIRUS REACTIVATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WORLD HEALTH ORGANIZATION;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CATARACT; DATA COLLECTION; ENVIRONMENTAL EXPOSURE; EYE NEOPLASMS; HERPES LABIALIS; HUMANS; QUALITY-ADJUSTED LIFE YEARS; RADIATION INJURIES; SKIN NEOPLASMS; SUNBURN; ULTRAVIOLET RAYS; VIRUS ACTIVATION; VITAMIN D DEFICIENCY; WORLD HEALTH;

EID: 44949116916     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyn017     Document Type: Article

References (91)

1. Murray C, Lopez A. The Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020: Harvard School of Public Health. Cambridge: Harvard University Press, 1996.
2. Murray CJ, Acharya AK. Understanding DALYs (disability-adjusted life years). J Health Econ 1997;16:703-30.
3. Lopez A, Mathers C, Ezzati M, Jamison D, Murray CJ. Global Burden of Disease and Risk Factors. New York: Copublished by The World Bank and Oxford University Press, 2006.
4. Pruss A, Kay D, Fewtrell L, Bartram J. Estimating the burden of disease from water, sanitation, and hygiene at a global level. Environ Health Perspect 2002;110:537-42.
5. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367:1747-57.
6. Concha-Barrientos M, Campbell-Lendrum D, Steenland K. Occupational Noise. In: Pruss-Ustun A, Campbell-Lendrum D, Corvalan CF, Woodward A (eds). Environmental Burden of Disease, Series No 9. Geneva: World Health Organization, 2004.
7. Lucas RM, McMichael A, Smith W, Armstrong B. Solar Ultraviolet Radiation. Global burden of disease from solar ultraviolet radiation. In: Pruss-Ustun A, Zeeb H, Mathers C, Repacholi MH (eds). Environmental Burden of Disease, Series No 13. Geneva: World Health Organization, 2006.
8. Jablonski NG, Chaplin G. The evolution of human skin coloration. J Hum Evol 2000;39:57-106.
9. Hill AB. The environment and disease: Association or causation? Proc R Soc Med 1965;58:295-300.
10. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998;88;15-19.
11. Desai M, Mehta S, Smith KR. Indoor smoke from solid fuels. In: Pruss-Ustun A, Campbell-Lendrum D, Corvalan CF, Woodward A (eds). Environmental Burden of Disease, Series No 4. Geneva: WHO, 2004.
12. Stouthard M, Essink-Bot M, Bonsel G et al. Disability Weights for Diseases in The Netherlands. Rotterdam, the Netherlands: Department of Public Health, Erasmus University, 1997.
13. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia. Canberra: Australian Institute of Health and Welfare, AIHW cat.no PHE 17 AIHW cat.no PHE 17, 1999, 245p.
14. NASA. NASA GSFC Total Ozone Mapping Spectrometer. Available at: http://iridl.ldeo.columbia.edu/SOURCES/.NASA/.GSFC/.TOMS/.ed. 2006.
15. Hoy WE. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider. Cancer 1996;77 2489-95.
16. Munyao TM, Othieno-Abinya NA. Cutaneous basal cell carcinoma in Kenya. East Afr Med J 1999;76:97-100.
17. Mora RG, Perniciaro C. Cancer of the skin in blacks. I. A review of 163 black patients with cutaneous squamous cell carcinoma. J Am Acad Dermatol 1981;5:535-43.
18. Marks R. Squamous cell carcinoma. Lancet 1996;347:735-38.
19. Harvey I, Frankel S, Marks R, Shalom D, Nolan-Farrell M. Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study. Br J Cancer 1996;74 1302-7.
20. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993;329:1147-51.
21. Cameron M. Pterygium Throughout the World. Illinois: Thomas, 1965.
22. Hirst LW. Distribution, Risk Factors, and Epidemiology of Pterygium. In: Taylor H (ed.). Pterygium. The Hague, The Netherlands: Kugler Publications, 2000. pp. 15-27.
23. Wong TY, Foster PJ, Johnson GJ, Seah SK, Tan DT. The prevalence and risk factors for pterygium in an adult Chinese population in Singapore: The Tanjong Pagar survey. Am J Ophthalmol 2001;131:176-83.
24. Panchapakesan J, Hourihan F, Mitchell P. Prevalence of pterygium and pinguecula: The Blue Mountains Eye Study. Aust N Z J Ophthalmol 1998;26 (Suppl 1):S2-5.
25. Taylor HR. The prevalence of corneal disease and cataracts in Australian aborigines in Northwestern Australia. Aust J Ophthalmol 1980;8 289-301.
26. Tortolero G, Narro J. Epidemiologic characteristics of pterygium in a rural community of Tlaxcala. Salud Publica Mex 1984;26:26-38.
27. Wlodarczyk J, Whyte P, Cockrum P, Taylor H. Pterygium in Australia: A cost of illness study. Clin Exp Ophthalmol 2001;29:370-75.
28. Ashaye AO. Pterygium in Ibadan. West Afr J Med 1991;10 232-43.
29. Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Version 1.0 ed: IARC CancerBase No. 5. Lyon, IARCPress, 2001.
30. Malik MO, El Sheikh FH. Tumors of the eye and adnexa in the Sudan. Cancer 1979;44:293-303.
31. Waddell KM, Lewallen S, Lucas SB, Atenyi-Agaba C, Herrington CS, Liomba G. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Ophthalmol 1996;80:503-8.
32. Sun EC, Fears TR, Goedert JJ. Epidemiology of squamous cell conjunctival cancer. Cancer Epidemiol Biomarkers Prev 1997;6:73-77.
33. Davis KJ, Cokkinides VE, Weinstock MA-O'Connell MC, Wingo PA. Summer sunburn and sun exposure among US youths ages 11 to 18: National prevalence and associated factors. Pediatrics 2002;110:27-35.
34. Bourke JF, Graham-Brown RA. Protection of children against sunburn: A survey of parental practice in Leicester. Br J Dermatol 1995; 133:264-66.
35. Boldeman C, Branstrom R, Dal H et al. Tanning habits and sunburn in a Swedish population age 13-50 years. Eur J Cancer 2001;37 2441-48.
36. Morris J, McGee R, Bandaranayake M. Sun protection behaviours and the predictors of sunburn in young children. J Paediatr Child Health 1998;34:557-62.
37. Hall HI, McDavid K, Jorgensen CM, Kraft JM. Factors associated with sunburn in white children aged 6 months to 11 years. Am J Prev Med 2001;20:9-14.
38. Hall HI, Rogers JD. Sun protection behaviors among African Americans. Ethn Dis 1999;9:126-31.
39. Axell T, Liedholm R. Occurrence of recurrent herpes labialis in an adult Swedish population. Acta Odontol Scand 1990;48:119-23.
40. Young TB, Rimm EB, D'Alessio DJ. Cross-sectional study of recurrent herpes labialis. Prevalence and risk factors. Am J Epidemiol 1988;127:612-25.
41. Reichart PA. Oral mucosal lesions in a representative cross-sectional study of aging Germans. Community Dent Oral Epidemiol 2000;28 390-98.
42. Young SK, Rowe NH, Buchanan RA. A clinical study for the control of facial mucocutaneous herpes virus infections. I. Characterization of natural history in a professional school population. Oral Surg Oral Med Oral Pathol 1976;41:498-507.
43. Embil JA, Stephens RG, Manuel FR. Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents. Can Med Assoc J 1975;113:627-30.
44. Gibson JJ, Hornung CA, Alexander GR, Lee FK, Potts WA, Nahmias AJ. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: Occurrence and determinants of infection. J Infect Dis 1990;162:306-12.
45. Vaughan V, McKay J, Behrman R, Nelson W. Nelson Textbook of Paediatrics. 11th edn. Philadelphia, PA: W.B. Saunders Company, 1979.
46. Norval M, Cullen AP, de Gruijl FR et al. The effects on human health from stratospheric ozone depletion and its interactions with climate change. Photochem Photobiol Sci 2007;6:232-51.
47. Ekanem EE, Bassey DE, Eyong M. Nutritional rickets in Calabar, Nigeria. Ann Trop Paediatr 1995;15:303-6.
48. Glerup H, Mikkelsen K, Poulsen L et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 2000;247:260-68.
49. Gloth FM III, Gundberg CM, Hollis BW, Haddad JG Jr., Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA 1995;274 1683-86.
50. Vieth R. Vitamin D nutrition and its potential health benefits for bone, cancer and other conditions. J Env Nutr Med 2001;11:275-91.
51. Gannage-Yared MH, Chemali R, Yaacoub N, Halaby G. Hypovitaminosis D in a sunny country: Relation to lifestyle and bone markers. J Bone Miner Res 2000;15:1856-62.
52. Lulseged S. Severe rickets in a children's hospital in Addis Ababa. Ethiop Med J 1990;28:175-81.
53. Hanley DA, Davison KS. Vitamin D insufficiency in North America. J Nutr 2005;135:332-37.
54. Rockell JE, Green TJ, Skeaff CM et al. Season and ethnicity are determinants of serum 25-hydroxyvitamin D concentrations in New Zealand children aged 5-14 y. J Nutr 2005;135:2602-08.
55. Zlotkin S. Vitamin D concentrations in Asian children living in England. Limited vitamin D intake and use of sunscreens may lead to rickets. Br Med J 1999;318:1417.
56. Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res 1993;3:395-401.
57. English DR, Armstrong BK, Kricker A, Winter MG, Heenan PJ, Randell PL. Case-control study of sun exposure and squamous cell carcinoma of the skin. Int J Cancer 1998;77:347-53.
58. Halder RM, Bridgeman-Shah S. Skin cancer in African Americans. Cancer 1995;75:667-73.
59. WHO. World Health Report 2001 - Mental Health: New understanding, new hope. Geneva: World Health Organization, 2001.
60. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001;63:8-18.
61. Scotto J, Fears TR, Kraemer KH, Fraumeni JF. Nonmelanoma skin cancer. In: Schottenfeld D, Fraumeni JF (eds). Cancer Epidemiology and Prevention. 2nd edn. New York: Oxford University Press, 1996. pp. 1313-30.
62. Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 1998;78:587-93.
63. Foster HM, Webb SJ. Skin cancer in the North Solomons. Aust N Z J Surg 1988;58:397-401.
64. Altman A, Rosen T, Tschen JA et al. Basal cell epithelioma in black patients. J Am Acad Dermatol 1987;17:741-45.
65. Fleming ID, Barnawell JR, Burlison PE, Rankin JS. Skin cancer in black patients. Cancer 1975;35:600-5.
66. Delcourt C, Carriere I, Ponton-Sanchez A, Lacroux A, Covacho MJ, Papoz L. Light exposure and the risk of cortical, nuclear, and posterior subcapsular cataracts: The Pathologies Oculaires Liees a l'Age (POLA) study. Arch Ophthalmol 2000;118:385-92.
67. Taylor HR, West SK, Rosenthal FS et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med 1988;319 1429-33.
68. Neale RE, Purdie JL, Hirst LW, Green AC. Sun exposure as a risk factor for nuclear cataract. Epidemiology 2003;14:707-12.
69. de Gruijl FR, Longstreth J, Norval M et al. Health effects from stratospheric ozone depletion and interactions with climate change. Photochem Photobiol Sci 2003;2:16-28.
70. Hu TS, Zhen Q, Sperduto RD, Zhao JL, Milton RC, Nakajima A. Age-related cataract in the Tibet Eye Study. Arch Ophthalmol 1989;107 666-69.
71. Klein BE, Klein R, Moss SE. Incident cataract surgery: The Beaver Dam eye study. Ophthalmology 1997;104:573-80.
72. Wang JJ, Mitchell P, Simpson JM, Cumming RG, Smith W. Visual impairment, age-related cataract, and mortality. Arch Ophthalmol 2001;119 1186-90.
73. Threlfall TJ, English DR. Sun exposure and pterygium of the eye: A dose-response curve. Am J Ophthalmol 1999;128:280-87.
74. Lee GA, Williams G, Hirst LW, Green AC. Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology 1994;101 360-64.
75. Lopez A. Comparative Risk Assessment: Interim Guidelines. Geneva: World Health Organization, 2002, pp. 1-19.
76. Armstrong BK. Melanoma of the skin. Br Med Bull 1984;40 346-50.
77. WHO. The World Health Report 2002. Reducing risks, Promoting Healthy Life: World Health Organization. 2002.
78. Garssen J, Norval M, el-Ghorr A et al. Estimation of the effect of increasing UVB exposure on the human immune system and related resistance to infectious diseases and tumours. J Photochem Photobiol B 1998;42:167-79.
79. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28.
80. Kricker A, Armstrong B. Does sunlight have a beneficial influence on certain cancers? Prog Biophys Mol Biol 2006;92:132-39.
81. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: A review (United States). Cancer Causes Control 2005; 16:83-95.
82. John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. Cancer Epidemiol Biomarkers Prev 1999;8:399-406.
83. Pritchard RS, Baron JA, Gerhardsson de Verdier M. Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. Cancer Epidemiol Biomarkers Prev 1996;5:897-900.
84. Tuohimaa P, Lyakhovich A, Aksenov N et al. Vitamin D and prostate cancer. J Steroid Biochem Mol Biol 2001;76:125-34.
85. Hughes AM, Amstrong BK, Vajdic CM et al. Sun exposure may protect against non-Hodgkin lymphoma: A case-control study. Int J Cancer 2004;112:865-71.
86. van der Mei IA, Ponsonby AL, Dwyer T et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: Case-control study. BMJ 2003;327:316.
87. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 2001;358:1500-3.
88. Lucas RM, Ponsonby AL. Considering the potential benefits as well as adverse effects of sun exposure: Can all the potential benefits be provided by oral vitamin D supplementation? Prog Biophys Mol Biol 2006;92:140-49.
89. AIHW. Health System Expenditures on Cancer and Other Neoplasms in Australia, 2000-2001. Canberra: Australian Institute of Health and Welfare, AIHW cat. no. HWE 29 AIHW cat. no. HWE 29, 2005.
90. Wolpowitz D, Gilchrest BA. The vitamin D questions: How much do you need and how should you get it? J Am Acad Dermatol 2006;54:301-17.
91. Lucas RM, Ponsonby AL. Ultraviolet radiation and health: Friend or foe. Med J Aust 2002;177:594-98, © Copyright 2002. The Medical Journal of Australia - reproduced with permission.